Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 Mar;23(3):884–892. doi: 10.1128/iai.23.3.884-892.1979

Immunoregulatory Responses in Experimental Disseminated Histoplasmosis: Lymphoid Organ Histopathology and Serological Studies

Ronald P Artz 1, Ward E Bullock 1
PMCID: PMC414245  PMID: 457263

Abstract

To study immunoregulatory mechanisms in systemic histoplasmosis, a highly reproducible model of infection was established in C3H/Anf mice. Intravenous inoculation of 6- to 8-week-old mice with from 5 × 105 to 10 × 105 cells of yeast-phase Histoplasma capsulatum strain G-217B produced disseminated infection that resolved over an 8-week period without therapeutic intervention. Serological studies demonstrated complement-fixing antibody production to yeast- and mycelial-phase antigens of H. capsulatum. Complement-fixing antibody to the former was detected at week 1, and it peaked at week 3 and declined thereafter. Complement-fixing antibody to mycelial-phase antigen(s) appeared later (week 3) and did not peak until week 18. Grossly, the spleens of infected mice were enlarged from three to four times normal size during peak infection, whereas the thymuses were markedly involuted. Conversely, at week 8 the average spleen size was considerably smaller and the thymic mass was increased relative to the mass at week 3. Histopathologically, the paracortical regions of lymph nodes and the white pulp (periarteriolar lymphocyte sheaths) and marginal zones of the spleen were heavily infiltrated by granulomata at week 1. By week 8, the infiltrates in these areas had largely resolved. Thymocytes were severely depleted from the cortical lobules of the thymus at week 1; however, thymic cellularity was restored by week 8. These reciprocal changes in cellularity of the thymus and spleen during active infection may be of importance with reference to the disturbances of immunoregulation that we have observed in Histoplasma-infected mice.

Full text

PDF
884

Images in this article

888Image
on p.888
889Image
on p.889
890Image
on p.890

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamson D. M., Cozad G. C. Effect of antilymphocyte serum on animals experimentally infected with Histoplasma capsulatum or Cryptococcus neoformans. J Bacteriol. 1969 Dec;100(3):1271–1276. doi: 10.1128/jb.100.3.1271-1276.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alford R. H., Goodwin R. A. Patterns of immune response in chronic pulmonary histoplasmosis. J Infect Dis. 1972 Mar;125(3):269–275. doi: 10.1093/infdis/125.3.269. [DOI] [PubMed] [Google Scholar]
  3. Alford R. H., Goodwin R. A. Variation in lymphocyte reactivity to histoplasmin during the course of chronic pulmonary histoplasmosis. Am Rev Respir Dis. 1973 Jul;108(1):85–92. doi: 10.1164/arrd.1973.108.1.85. [DOI] [PubMed] [Google Scholar]
  4. Artz R. P., Bullock W. E. Immunoregulatory responses in experimental disseminated histoplasmosis: depression of T-cell-dependent and T-effectory responses by activation of splenic suppressor cells. Infect Immun. 1979 Mar;23(3):893–902. doi: 10.1128/iai.23.3.893-902.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Berry C. L. Modification of the host response in experimental histoplasmosis. J Pathol. 1969 Apr;97(4):653–664. doi: 10.1002/path.1710970410. [DOI] [PubMed] [Google Scholar]
  6. Berry C. L. The development of the granuloma of histoplasmosis. J Pathol. 1969 Jan;97(1):1–10. doi: 10.1002/path.1710970102. [DOI] [PubMed] [Google Scholar]
  7. Berry C. L. The production of disseminated histoplasmosis in the mouse: the eff4ects of changes in reticulo-endothelial function. J Pathol. 1969 Mar;97(3):441–457. doi: 10.1002/path.1710970304. [DOI] [PubMed] [Google Scholar]
  8. Bullock W. E., Jr Perturbation of lymphocyte circulation in experimental murine leprosy. II. Nature of the defect. J Immunol. 1976 Oct;117(4):1171–1178. [PubMed] [Google Scholar]
  9. Chandler J. W., Jr, Smith T. K., Newberry W. M., Jr, Chin T. D., Kirkpatrick C. H. Immology of the mycoses. II. Characterization of the immunoglobulin and antibody responses in histoplasmosis. J Infect Dis. 1969 Mar;119(3):247–254. doi: 10.1093/infdis/119.3.247. [DOI] [PubMed] [Google Scholar]
  10. Chick E. W., Roberts G. D. The varying susceptibility of different genetic strains of laboratory mice to Histoplasma capsulatum. Mycopathol Mycol Appl. 1974 Apr 30;52(3):251–253. doi: 10.1007/BF02198750. [DOI] [PubMed] [Google Scholar]
  11. Cozad G. C., Lindsey T. J. Effect of cyclophosphamide on Histoplasma capsulatum infections in mice. Infect Immun. 1974 Feb;9(2):261–265. doi: 10.1128/iai.9.2.261-265.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Davies S. F., Khan M., Sarosi G. A. Disseminated histoplasmosis in immunologically suppressed patients. Occurrence in a nonendemic area. Am J Med. 1978 Jan;64(1):94–100. doi: 10.1016/0002-9343(78)90183-3. [DOI] [PubMed] [Google Scholar]
  13. Ford W. L. Lymphocyte migration and immune responses. Prog Allergy. 1975;19:1–59. doi: 10.1159/000313381. [DOI] [PubMed] [Google Scholar]
  14. Ford W. L. The recruitment of recirculating lymphocytes in the antigenically stimulated spleen. Specific and non-specific consequences of initiating a secondary antibody response. Clin Exp Immunol. 1972 Oct;12(2):243–254. [PMC free article] [PubMed] [Google Scholar]
  15. Howard D. H., Otto V. Experiments on lymphocyte-mediated cellular immunity in murine histoplasmosis. Infect Immun. 1977 Apr;16(1):226–231. doi: 10.1128/iai.16.1.226-231.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Huldt G., Gard S., Olovson S. G. Effect of Toxoplasma gondii on the thymus. Nature. 1973 Aug 3;244(5414):301–303. doi: 10.1038/244301a0. [DOI] [PubMed] [Google Scholar]
  17. Kauffman C. A., Israel K. S., Smith J. W., White A. C., Schwarz J., Brooks G. F. Histoplasmosis in immunosuppressed patients. Am J Med. 1978 Jun;64(6):923–932. doi: 10.1016/0002-9343(78)90445-x. [DOI] [PubMed] [Google Scholar]
  18. Kitahara M., Kobayashi G. S., Medoff G. Enhanced efficacy of amphotericin B and rifampicin combined in treatment of murine histoplasmosis and blastomycosis. J Infect Dis. 1976 Jun;133(6):663–668. doi: 10.1093/infdis/133.6.663. [DOI] [PubMed] [Google Scholar]
  19. Linna T. J., Cohen E. P. Increased frequency of thymus-derived cells in the spleens of sheep erythrocyte-stimulated mice. Immunol Commun. 1973;2(6):535–546. doi: 10.3109/08820137309022825. [DOI] [PubMed] [Google Scholar]
  20. Murray P. K., Jennings F. W., Murray M., Urquhart G. M. The nature of immunosuppression in Trypanosoma brucei infections in mice. II. The role of the T and B lymphocytes. Immunology. 1974 Nov;27(5):825–840. [PMC free article] [PubMed] [Google Scholar]
  21. Newberry W. M., Jr, Chandler J. W., Jr, Chin T. D., Kirkpatrick C. H. Immunology of the mycoses. I. Depressed lymphocyte transformation in chronic histoplasmosis. J Immunol. 1968 Feb;100(2):436–443. [PubMed] [Google Scholar]
  22. ROWLEY D. A., HUBER M. Growth of Histoplasma capsulatum in normal, superinfected, and immunized mice. J Immunol. 1956 Jul;77(1):15–23. [PubMed] [Google Scholar]
  23. Reddy P., Gorelick D. F., Brasher C. A., Larsh H. Progressive disseminated histoplasmosis as seen in adults. Am J Med. 1970 May;48(5):629–636. doi: 10.1016/0002-9343(70)90014-8. [DOI] [PubMed] [Google Scholar]
  24. Rifkind D., Marchioro T. L., Schneck S. A., Hill R. B., Jr Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Clinical, microbiologic, neurologic and pathologic features. Am J Med. 1967 Jul;43(1):28–38. doi: 10.1016/0002-9343(67)90146-5. [DOI] [PubMed] [Google Scholar]
  25. SALVIN S. B. Cultural and serologic studies on nonfatal histoplasmosis in mice, hamsters, and guinea pigs. J Infect Dis. 1954 Jan-Feb;94(1):22–29. doi: 10.1093/infdis/94.1.22. [DOI] [PubMed] [Google Scholar]
  26. SALVIN S. B. Further studies on immunization of mice against Histoplasma capsulatum. Am J Hyg. 1955 Jan;61(1):72–81. doi: 10.1093/oxfordjournals.aje.a119741. [DOI] [PubMed] [Google Scholar]
  27. SASLAW S., SCHAEFER J. Relation of sex and aged to resistance of mice to experimental histoplasma infections. Proc Soc Exp Biol Med. 1955 Nov;90(2):400–402. doi: 10.3181/00379727-90-22046. [DOI] [PubMed] [Google Scholar]
  28. Simu G., Toma V., Nestor D., Roşculet M. S. Studies on the mechanisms of thymus involution in animals with transplanted tumors. Oncology. 1968;22(1):36–48. doi: 10.1159/000224437. [DOI] [PubMed] [Google Scholar]
  29. Smith J. W., Utz J. P. Progressive disseminated histoplasmosis. A prospective study of 26 patients. Ann Intern Med. 1972 Apr;76(4):557–565. doi: 10.7326/0003-4819-76-4-557. [DOI] [PubMed] [Google Scholar]
  30. Stobo J. D., Paul S., Van Scoy R. E., Hermans P. E. Suppressor thymus-derived lymphocytes in fungal infection. J Clin Invest. 1976 Feb;57(2):319–328. doi: 10.1172/JCI108283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tewari R. P., Berkhout F. J. Comparative pathogenicity of albino and brown types of Histoplasma capsulatum for mice. J Infect Dis. 1972 May;125(5):504–508. doi: 10.1093/infdis/125.5.504. [DOI] [PubMed] [Google Scholar]
  32. Tewari R. P., Sharma D., Solotorovsky M., Lafemina R., Balint J. Adoptive transfer of immunity from mice immunized with ribosomes or live yeast cells of Histoplasma capsulatum. Infect Immun. 1977 Mar;15(3):789–795. doi: 10.1128/iai.15.3.789-795.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Williams D. M., Graybill J. R., Drutz D. J. Histoplasma capsulatum infection in nude mice. Infect Immun. 1978 Sep;21(3):973–977. doi: 10.1128/iai.21.3.973-977.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES